Supplement × Prescription·a caution·Emerging evidence

Chromium + Tirzepatide

Caution Emerging evidence

Chromium may enhance insulin signaling and glucose metabolism, adding to tirzepatide's glucose-lowering effect.

From the database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, and the recommendation.

Substances
Pair type
Caution
Evidence
Emerging
Source citations
3
Scope
Supplement × Prescription
Last verified
June 1, 2026
CautionEmerging evidence

What is happening. Chromium may enhance insulin signaling and glucose metabolism, adding to tirzepatide's glucose-lowering effect.

Mechanism. Chromium may potentiate insulin signaling. Tirzepatide lowers glucose through GIP/GLP-1 receptor activation.

Recommendation. Low-dose chromium in a multivitamin is usually low risk. Use caution with high-dose chromium supplements and monitor glucose when starting or changing dose.

Stack Score

How it moves the number.

Effect on the composite score

If both Chromium and Tirzepatide are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).

The full algorithm, the clamping rules, and four worked stacks are at /methodology/stack-score.

Sources

Sources, by evidence tier.

Every claim on this page is cited. PMIDs link straight to PubMed.

Check your full routine

One pair was the worked example.

Drop your supplements and prescriptions into NutriStack and it runs every pair at once: every interaction, synergy, timing rule, and contraindication, each linked to its primary source.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.